DOBUTAMINE

Product NDC
51662-1337
11-digit product format
516621337
Labeler code
51662
Product ID
51662-1337_11c1b110-433c-7887-e063-6294a90a1e52
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
DOBUTAMINE
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Labeler
HF Acquisition Co LLC, DBA HealthFirst
Application
ANDA074086
Marketing category
ANDA
Marketing start
2018-11-26
Substance
DOBUTAMINE HYDROCHLORIDE
Active strength
12.5 mg/mL
Pharmacologic classes
Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
DOBUTAMINE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DOBUTAMINE HYDROCHLORIDE12.5 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii0WR771DJXV
Rxcui1812168

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c061d745-4e41-be68-87e9-bad2cb726830Product name220240208
020518de-5dfd-f3a9-9c93-8015dad30497Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51662-1337-12020-02-07C16284748780-19d75b9d0-509b-f424-e053-dadaa90a57ceDOBUTAMINE INJECTION, USP 250mg PER 20mL VIAL
51662-1337-12020-01-31C16284748780-19d75b9d0-509b-f424-e053-dadaa90a57ceDOBUTAMINE INJECTION, USP 250mg PER 20mL VIAL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51662-1337-1DOBUTAMINE20 mL in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION, CONCENTRATE206
51662-1337-2DOBUTAMINE1 in 1 POUCHINJECTION, SOLUTION, CONCENTRATE16
51662-1337-2DOBUTAMINE20 mL in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION, CONCENTRATE206
51662-1337-3DOBUTAMINE10 in 1 CASEINJECTION, SOLUTION, CONCENTRATE106

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51662-1337DOBUTAMINE INJECTION, SOLUTION, CONCENTRATE [HF ACQUISITION CO LLC, DBA HEALTHFIRST]6Current NDC, Legacy NDC, 4 package rows20240220_7b9ea626-7072-2e77-e053-2a91aa0a9215.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1812168DOBUTamine 250 MG in 20 ML InjectionPSN7b9ea626-7072-2e77-e053-2a91aa0a92156
181216820 ML dobutamine 12.5 MG/ML InjectionSCD7b9ea626-7072-2e77-e053-2a91aa0a92156
1812168dobutamine (as dobutamine HCl) 250 MG per 20 ML InjectionSY7b9ea626-7072-2e77-e053-2a91aa0a92156
1812168dobutamine 250 MG per 20 ML InjectionSY7b9ea626-7072-2e77-e053-2a91aa0a92156

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
51662-1337-15166213370120 mL in 1 VIAL, SINGLE-DOSE (51662-1337-1) 20 ml2018-11-260000-00-00NoNoCurrent
51662-1337-2516621337021 in 1 POUCHHistorical
51662-1337-35166213370310 POUCH in 1 CASE (51662-1337-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1337-2) / 20 mL in 1 VIAL, SINGLE-DOSE10 pouch2022-06-120000-00-00NoNoCurrent